PROCEDURE REF NO SABP/EXECUTIVE BOARD/0017
|
|
- Morgan Casey
- 5 years ago
- Views:
Transcription
1 PROCEDURE REF NO SABP/EXECUTIVE BOARD/0017 NAME OF PROCEDURE: Medicines Procedure: Patient Group Directions for the Administration of Hepatitis B Vaccine for SABP Drug and Alcohol Teams. PURPOSE OF PROCEDURE: WHAT THE PROCEDURE WILL ACHIEVE? To ensure all members of staff involved in the prescribing, administering and safe custody of vaccines are fully aware of the necessary steps required. Provide guidance to all staff involved in the administration of Vaccines through patient group directions. WHO NEEDS TO KNOW ABOUT IT? All clinical /practitioners within the Drug and Alcohol Services and Pharmacy staff. DATE APPROVED: 6 th April 2017 VERSION NUMBER: 4.0 APPROVING COMMITTEE: Executive Board DATE OF IMPLEMENTATION: 28 th September 2017 DATE OF FORMAL REVIEW: April 2020 AUTHOR/REVIEWER: Simon Whitfield (Chief Pharmacist) Mike Flanagan (Clinical Lead) Lynda Winn (Clinical Nurse Specialist). DISTRIBUTION: SABP Substance Misuse Teams 1
2 VERSION CONTROL SHEET Version Date Author Status Comment Mayvis Oddoye 2 7/07/10 Lynda Winn and Simon Whitfield Major review to ensure presentation complies with legislative requirements 3 June 2014 Fiona Minor amendments Lockwood and Lynda Winn 3.1 Nov 2016 Simon Whitfield Draft Rationalisation of products 3.1 Dec 16 Simon Whitfield Draft Reviewed by Fiona Lockwood 3.2 Jan 17 Simon Whitfield Draft Reviewed by Linda Wynn 3.3 March 17 Simon Whitfield Draft Added clarity over competency requirements and 2
3 annual sign off 3.4 April 17 Simon Whitfield Draft Presented at PAG. Query regarding support for nurses who fail competency assessment. 4 July 17 Approved 3
4 Summary of Changes since Version 3 Page/Paragraph/ Appendix Number Original / New / Amendment / Deleted Statement (select the appropriate action) PGD revised to include Hepatitis B (Engerix B) vaccine only. All other references to other vaccines and brands and preparations have been removed and are no longer covered by this PGD. If a member of staff fails the competency assessment then a tailored training package will be developed, using the available online training resources, coaching and supervision, to support and enable the member of staff to attain the required competency. 4
5 PATIENT GROUP DIRECTION (PGD) FOR THE ADMINISTRATION OF HEPATITIS VACCINES BY REGISTERED NURSES WORKING IN SABP SUBSTANCE MISUSE SERVICES Version Number: 4 Patient Group Direction drawn up by: NAME: TITLE: Simon Whitfield Mike Flanagan Lynda Winn Chief Pharmacist Clinical Lead for Substance Misuse Clinical Nurse Specialist Patient Group Direction authorised by: Medical Lead Executive Medical Director On behalf of the organisation Chief Pharmacist Director of Nursing Date Protocol Agreed: July 2017 Proposed Review Date: April 2020 Date Protocol Expires: July
6 1. Scope 1.1 The Patient Group Directions included in this document are: Hepatitis B Vaccine (Energix B ) 1.2 If a nurse is asked to supply or supply and administer a medicine not covered by this or any other PGD then a prescription or named written direction is required from a prescriber first. 2. Rationale for Patient Group Directions for the administration of vaccines 2.1 To enable suitably qualified health professionals, who are deemed to be competent, to administer vaccines for people who use our drug and alcohol services 2.2 Key Documents: NMC code of conduct RCN PGD document Green book (2006) 3 rd edition and on-line updates HPA Core Curriculum for Immunisation Training 3. General Guidance for the Administration of Vaccines 3.1 General - The identity of the vaccine must be checked to ensure the right product is used in the appropriate way on every occasion. - The expiry date must be noted. - Vaccines must not be used after the expiry date on the label. - The date of immunisation, title of vaccine and batch number must be recorded on the recipient s record. - It is considered good practice to record the site of administration. - The recommended storage conditions must have been observed. 6
7 4. Storage, Distribution and Disposal of Vaccines - The Unit Manager should be responsible for the safe storage of vaccines and must have a nominated deputy to cover times of absence. There should be written procedures for storage, distribution and disposal. This should include procedures in case the refrigerator temperature is out of range. - Manufacturers recommendations on storage must be observed. On receipt, vaccines should be checked against the order, examined for leakage or other damage and immediately refrigerated at between 2 0 C and 8 0 C. Vaccines must not be stored below freezing (0 0 C) as this may cause deterioration of the vaccine and breakage of the container. - Vaccines should be stored in the refrigerator in the manufacturer s box as this protects the vaccine from the light and also contains product information. Do not store in the refrigerator door. Allow room for air to circulate in the refrigerator. 5. Cleaning of Skin - The skin does not need to be cleaned as a matter of routine, the exception being if the skin is dirty. 6. Route of Administration - Hepatitis B vaccines must be given as an Intramuscular Injection using the deltoid site. 7. Administration Outside Hospital Based Premises Refer to the BBV Policy document where details are given in full. 7
8 8. Advice and Referral If a person using our services falls outside the guidelines for vaccination using the PGD medical advice should be sought. 9. Before Giving Vaccine - Patients should be advised of the contra-indications. - Adrenaline 1:1000 and a laerdal facemask must be available. - The consent form must be signed. - Informed consent to be obtained from the patient immediately prior to administration of vaccine, having been given clear explanation of which vaccines are to be administered and their possible side effects. Patient information leaflets should be made available. 10. Contra-indications for Immunisation - Postpone vaccination if the patient reports pyrexia/unwell or is being prescribed antibiotics. - Seek doctor s advice if the patient has had: A severe local or systemic reaction to a previous dose of the vaccine Severe adverse reaction to antibiotics especially neomycin Has an immunosuppressant illness 11. Post Vaccination - Ask patient to wait in waiting room for 10 minutes. - Ensure appropriate advice is given re allergic reactions. - Advise the patient that if any local reaction does not disappear within 1-2 days or if the patient experiences other severe symptoms e.g. confusion, persistent drowsiness etc, advise them to contact their General Practitioner. 8
9 12. Record Keeping - All immunisations, with their batch numbers and expiry date, should be entered in the patient notes using the vaccination record. - Details should be entered onto the electronic patient record. - Any previous vaccination history should be entered in patient notes. - Any unusual side effects should be recorded on the yellow card available in the BNF and online: Authorised Staff Characteristics Professional qualifications to be held by staff administering vaccines under this Patient Group Direction Authorised nurses must hold a current nursing registration with the Nursing and Midwifery Council. Have a minimum of 6 months experience in substance misuse. Registered nurse working within SABP Competence Each authorised individual administering vaccines in accordance with this Patient Group Direction should be able to demonstrate competency in the areas below, to their line manager on an annual basis: Administration of vaccines including knowledge of recommended sites and routes and understanding of passive / active immunity, storage requirements for vaccines. Recognition and management of anaphylaxis. Self-directed learning programme or training for Hepatitis B vaccination and maintain own level of updating CPD. HPA Core Curriculum of Immunisation including competency checklist to be updated yearly. RCN PGD Document. Hepatitis B Vaccination relevant chapters in Green Book (2006) 3 rd edition and on-line updates. Yearly CPR and anaphylaxis update as per SABP requirements. Assessment of competency The line manager or delegated authority can assess competency via a group assessment process to ensure consistency of practice across the service, however they 9
10 must be assured that each individual is competent to practice within the framework of the PGD. If a member of staff fails the competency assessment then a tailored training package will be developed by their line manager, using the available online training resources, coaching and supervision, to support and enable the member of staff to attain the required competency. Record of competence and authorisation The record of competence and authorisation forms found in section 17 must be completed and updated on an annual basis. 10
11 14. PGD for the Supply/Administration of: HEPATITIS B VACCINE Engerix B To Adults accessing SABP Substance Misuse Services. Specific Clinical Condition Indication Specific inclusion criteria Active immunisation for Adults requiring immunisation from Hepatitis B virus infection. Adults who present to SABP Substance Misuse Services and who: Are at risk due to their substance misuse, sexual behaviour or other lifestyle behaviours. Informed consent to be obtained from the client immediately prior to administration of vaccine, having been given clear explanation of which vaccine is to be administered and possible side effects. Patient information leaflet should be made available. Specific exclusion criteria Febrile illness. True allergy or anaphylaxis to any component of vaccine (refer to SPC Post exposure prophylaxis. Previous confirmed Hepatitis B infection. Pregnancy (unless definitive risk of Hepatitis B Refer to doctor). No consent. Cautions There are 2 volumes of Engerix B vaccine available. Ensure the 1ml volume (20 micrograms/1ml) is used. Action if excluded Advice about protective effects of the vaccine and risks of infection and disease complications. Inform patient to return when febrile illness resolved. Patients with Hepatitis B or allergy discuss with GP / specialist, advice re minimisation of risk. Document advice given. Reschedule vaccinations. Action if client declines Advise on minimisation of risk and document advice given. Inform or refer to GP if appropriate. Referral arrangements for medical advise Discuss with team doctor if available, refer to GP/Walk-In Centre or Accident and Emergency. 11
12 Name of medicine Hepatitis B recombinant vaccine adsorbed Engerix B Legal Status POM Dose/route/frequency Engerix B Adults and Children over 16 years: Accelerated course: 1mL (20 micrograms) by IM injection into the deltoid region for initial dose; repeat at 1 month, 2 months and at 12 months after initial dose. Super Accelerated course for adults over 18 years: 1mL (20 micrograms) by IM injection into the deltoid region for initial dose; repeat at 7 days, 21 days and fourth dose at 12 months after initial dose. Refer to Green Book (2006) and on-line updates for further schedules. Specific advice/warnings Soreness at injection site, fever, headache or myalgia may occur Seek medical advice if a systemic reaction is experienced. Rare severe reactions including encephalitis, anaphylaxis, jaundice or neuritis should be reported using the Yellow Card system. Reporting procedure of Adverse Reactions Any serious adverse reaction to the vaccine should be documented in the medical records. The GP should also be informed. Additional Facilities Anaphylaxis pack including Epinephrine (Adrenaline) (1 in 1000, 1ml ampoule), laerdal face mask or resuscitation face shield as a minimum. Facilities for safe disposal of needles, syringes, vials and other clinical waste. Hand decontamination or washing facilities. Vaccines to be stored as specified in their summaries of product characteristics and Trust / Practice medicines storage procedures in a refrigerator between 2 and 8 C and temperature monitored and recorded each working day and defrosted regularly. Additional Information A single booster dose five years after completion of the primary course for individuals who continue to be at risk of infection unless they have already received a booster dose following possible exposure. The vaccine must not be administered by intradermal or intravascular routes The vaccine must not be administered in the buttock as this may result in a lower immune response Vaccine should be maintained at a temperature of 2 0 to 8 0 C. If the vaccine has been frozen, the vaccine should be discarded 12
13 In some circumstances, the recommendations regarding vaccines given in the Green Book may differ from those in the manufacturers SPC or datasheet. Where this is the case, the recommendations given are based on the current expert advice received from the Joint Committee on Vaccination and Immunisation (JCVI) and should be followed. 13
14 14. Record of competency and authorisation. The forms below must be completed and updated on an annual basis. Annual Individual Authorisation: By signing this Patient Group Direction (PGD) you are indicating that you agree to its contents and that you will work within it. This PGD does not remove inherent professional obligations or accountability. It is the responsibility of each professional to practice only within the bounds of their own competence and scope of practice. Practitioner: I confirm that I have read and understood the content of this patient group direction and that I am willing and competent to work under it within my professional code of conduct. Signed Date Name (Print).. Authorising Manager: I confirm the above named nurse has satisfactorily completed the annual competency assessment and is authorised to work under this PGD. Signed.Date Name (Print) Team Authorising Consultant: I confirm the above named nurse has satisfactorily completed the annual competency assessment and is authorised to work under this PGD. Signed Date. Name (Print) Team 14
15 SABP Partnership NHS Foundation Trust Team Name: The following named individuals have completed an annual competency assessment and are authorised to work under this PGD. Name of Nurse Date of authorisation Signature of line manager 15
16 15. References British National Formulary March 2016 Immunisation Against Infectious Diseases HMSO Websites - Resuscitation Council (UK) Electronic Medicines Compendium - Vaccine Update Bulletin - BNF - Consent Topics/GreenBook/GreenBookGeneralInformation/ - PGD and UK guidance on best practise in vaccine administration 16
Document Details. Patient Group Direction
Document Details Title Patient Group Direction (PGD) Hepatitis B Vaccine (Engerix ) Trust Ref No 1505-41182 Local Ref (optional) Main points the Immunisation against Hepatitis B document covers Who is
More informationDocument Details Patient Group Direction Hepatitis A vaccine (Havrix Monodose ) Trust Ref No Local Ref (optional) Main points the
Document Details Title Patient Group Direction Hepatitis A vaccine (Havrix Monodose ) Trust Ref No 1506-41174 Local Ref (optional) Main points the Active immunisation against infection caused by Hepatitis
More informationSAMPLE. PGD Reviewed by: Chris Faldon, John Maloney, Tim Patterson, Adrian MacKenzie, Claire Stein
Patient Group Direction for the supply or administration of haemophilus influenzae type B and meningococcal conjugate vaccine to children requiring immunisation as part of the national childhood vaccination
More informationGG&C PGD ref no: 2016/1338 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT
GG&C PGD ref no: 2016/1338 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: For active immunisation of individuals
More informationby registered nurses employed by NHS Hertfordshire or Hertfordshire GP Practices and signatories to the PGD
Notice to all staff: NHS Hertfordshire Patient Group Directions (PGDs) may only be used by members of the healthcare professions named on the title page and only if each professional has individually been
More informationCommunity Psychiatric Nurse. Consultant Psychiatrist, Substance Misuse Services
PATIENT GROUP DIRECTION (PGD) FOR THE ADMINISTRATION OF HEPATITIS A VACCINE (HAVRIX MONODOSE VACCINE) BY REGISTERED NURSES WORKING IN THE COMMUNITY SUBSTANCE MISUSE TEAMS Version Number : 2 Patient Group
More informationPATIENT GROUP DIRECTION. Oral (live attenuated) Typhoid Vaccine (Ty21a) (Vivotif )
PATIENT GROUP DIRECTION Administration of: Oral (live attenuated) Typhoid Vaccine (Ty21a) (Vivotif ) By: Practice Nurses In: General Practice It is the responsibility of the professional working under
More informationSAMPLE. PGD reviewed by: Dr Tim Patterson, Chris Faldon, John Maloney, Adrian Mackenzie
Patient Group Direction for the Supply or Administration of combined Diphtheria, Tetanus, acellular Pertussis, inactivated Polio vaccine and Haemophilus type b conjugate Vaccine (Infanrix-IPV-HIB) to children
More informationAdministration of Hepatitis A and B Vaccine
PRACTICE: Ref No: PGD/ONEL/2011/006 Valid from December 2011 Valid to December 2013 Supersedes PGD: Any previous PGD used to administer Twinrix Adult and Paediatric vaccine Professional groups covered
More informationThis document expires on Patient Group Direction No. VI 5
Patient Group Direction (PGD) for The Administration of Combined Adsorbed Diphtheria, Tetanus, Pertussis, (Acellular Component) and Inactivated Poliomyelitis Vaccine (Infanrix-IPV ) to children aged between
More informationThis document expires on Patient Group Direction No. VI 7
Patient Group Direction (PGD) for The Administration of Combined low-dose Diphtheria, Tetanus, and Inactivated Polio Vaccine (Revaxis ) to individuals aged over 10 years, by Registered Nurses employed
More informationThis document expires on Patient Group Direction No. VI 11
Patient Group Direction (PGD) for The Administration of Combined Inactivated Hepatitis A & Hepatitis B Vaccine (Twinrix adult, Twinrix paediatric) to Adults and Children over one year by Registered Nurses
More informationClinical Condition Indication:
GG&C PGD ref no: 2012/943 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: For active immunisation of individuals
More informationPatient Group Direction for Combined Hepatitis A & B vaccine Version: Hep A + B Start Date: 1 st January 2014 Expiry Date: 31 st December 2015
Patient Group Direction for Combined Hepatitis A & B vaccine Version: Hep A + B 2014.1 Start 1 st January 2014 Expiry 31 st December 2015 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS:
More informationPGD No Administration of Human Papillomavirus Vaccine (HPV) Types 6, 11, 16 and 18 - Gardasil - September 2012
Notice to all staff: NHS Hertfordshire Patient Group Directions (PGDs) may only be used by members of the healthcare professions named on the title page and only if each professional has individually been
More informationGG&C PGD ref no: 2016/1408 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT
GG&C PGD ref no: 2016/1408 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Active immunisation against disease
More informationClinical Condition Indication:
Patient Group Direction ( for Health Care GG&C PGD ref no: 2018/1611 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition
More informationPatient Group Direction Hepatitis A vaccine Version: Hepatitis A 2015 Start Date: 1 st July 2015 Expiry Date:30 th June 2018
Patient Group Direction Hepatitis A vaccine Version: Hepatitis A 2015 Start 1 st July 2015 Expiry 30 th June 2018 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS: BLACKPOOL
More informationThis document expires on Patient Group Direction Number VI 19
Patient Group Direction (PGD) for The Administration of Pneumococcal Polysaccharide Vaccine (PPV, Pneumovax II ) to adults over 65 years and at risk groups aged 2 years and over, by Registered Nurses employed
More informationGG&C PGD ref no: 2018/1603 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT
GG&C PGD ref no: 2018/1603 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Active immunisation
More informationPATIENT GROUP DIRECTION PROCEDURE
PATIENT GROUP DIRECTION PROCEDURE Date approved 2 October 2015 Version 3 Approved by Yvette Oade, Chief Medical Officer Procedure Lead Clinical Governance Lead - Medicines Management Procedure Author Karen
More informationTHIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS:
Patient Group Direction for Pneumococcal polysaccharide vaccine VERSION: PNEUMOCOCCAL POLY-2013.1 (Pneumovax II ) Start 1 st May 2013 Expiry 30 th April 2015 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED
More informationPatient Group Direction For the supply and administration of
Patient Group Direction For the supply and administration of COMBINED HEPATITIS A AND HEPATITIS B VACCINE TWINRIX PAEDIATRIC For Children aged 1 year to under 16 years TWINRIX ADULT For Adults and Adolescents
More informationPatient Group Direction For the supply and administration of
Patient Group Direction For the supply and administration of Adsorbed low dose DIPHTHERIA/TETANUS/acellular PERTUSSIS/ inactivated POLIO REPEVAX Vaccine (dtap/ipv) Or Adsorbed DIPHTHERIA/TETANUS/acellular
More informationHEPATITIS A + TYPHOID VACCINE
GG&C PGD ref no: 2017/1522 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Indicated for active immunisation
More informationPatient Group Direction for Varicella vaccine Version: Varicella Start Date: 1 st May 2014 Expiry Date: 30 th April 2017
Patient Group Direction for Varicella vaccine Version: Varicella 2014.1 Start Date: 1 st May 2014 Expiry Date: 30 th April 2017 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS:
More informationDocument Details. Ibuprofen 200mg tablets and Ibuprofen oral liquid 100mg in 5ml
Title Document Details Patient Group Direction (PGD) Ibuprofen 200mg tablets and Ibuprofen oral liquid 100mg in 5ml Trust Ref No 1445-36348 Local Ref (optional) Main points the document The treatment of
More informationGG&C PGD ref no: 2017/1427 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT
GG&C PGD ref no: 2017/1427 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Active immunisation against rotavirus.
More informationDeveloped By Name Signature Date
Patient Group Direction 2155 version 2.0 Administration / Supply of Inhaled Salbutamol in Asthma by Registered Practitioners employed by Torbay and South Devon NHS Foundation Trust Date of Introduction:
More informationGG&C PGD ref no: 2018/1589 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT
GG&C PGD ref no: 2018/1589 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Individuals requiring active immunisation
More informationPatient Group Direction (PGD) Number :
Notice to all staff: The Patient Group Directions (PGDs) for the Hertfordshire and South Midlands Area Team may only be used by members of the healthcare professions named on the title page, and only if
More informationPolicy and Procedure for the Development, Approval and Implementation of Patient Group Directions in NHS Haringey Clinical Commissioning Group
BEFORE USING THIS POLICY ALWAYS ENSURE YOU ARE USING THE MOST UP TO DATE VERSION Policy and Procedure for the Development, Approval and Implementation of Patient Group Directions in NHS Haringey Clinical
More informationPatient Group Direction For The Administration Of H1N1 (Swine Flu) vaccine
n Patient Group Direction For The Administration Of H1N1 (Swine Flu) vaccine October 2009 PGD version template-2009.1 Page 1 of 8 Rationale Patient Group Direction For The Administration Of H1N1 (Swine
More informationDocument Details. Patient Group Direction
Document Details Title Patient Group Direction (PGD) Salbutamol Aerosol Inhaler and salbutamol Nebulised Solution Trust Ref No 1569-34313 Local Ref (optional) Main points the document Treatment of acute
More informationCLINICAL CONTENT OF PATIENT GROUP DIRECTION FOR PNEUMOCOCCAL CONJUGATE VACCINE (Prevenar 13 )
Patient Group Direction for Pneumococcal Conjugate Vaccine (Prevenar 13 ) Version: PNEUMOCOCCAL CONJUGATE 2014.1 Start 1 st February 2014 Expiry 31 st January 2017 THIS PATIENT GROUP DIRECTION HAS BEEN
More informationPrescription only medicines (POMs)
Prescription only medicines (POMs) 2017 Learning objectives Explain the legal framework with which registered health care professionals can administer prescription only medicines Define the role and limitations
More informationExpiry Date: September 2009 Template Version: Page 1 of 7
GG&C PGD ref 2007/467 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Exclusion criteria:
More informationPatient Group Direction For the supply and administration of
Patient Group Direction For the supply and administration of HAEMOPHILUS INFLUENZAE TYPE B AND MENINGOCOCCAL C CONJUGATE VACCINE (HIB-MenC) MENITORIX Vaccine By Registered Nurse/Midwife/Health Visitor
More informationPatient Group Direction
This Patient Group Direction (PGD) must only be used by registered health professionals who have been named and authorised by their organisation to practice under it. The most recent and in date final
More informationThis Patient Group Direction has been developed/reviewed in accordance with NICE guidance by:- Position of Signatory Name Signed Date
Patient Group Direction Administration of Hepatitis B Vaccine By Registered Nurses employed by GP Practices within Stafford & Surrounds Clinical Commissioning Group This Patient Group Direction has been
More informationPATIENT GROUP DIRECTION (PGD)
PATIENT GROUP DIRECTION (PGD) SUPPLY OF NALOXONE HYDROCHLORIDE INJECTION BY REGISTERED NURSES TO CLIENTS BEING RELEASED FROM HMP FORD Version Number: 01HMP Patient Group Direction originally drawn up by:
More informationSAFE HANDLING OF VACCINES
STANDARD OPERATING PROCEDURE SAFE HANDLING OF VACCINES Issue History Issue Version One Purpose of Issue/Description of Change Planned Review Date To ensure vaccines are stored in accordance with manufacturers
More informationPatient Group Direction for Varicella vaccine Version: Varicella Start Date: 1 st April 2016 Expiry Date: 31 st March 2019
Patient Group Direction for Varicella vaccine Version: Varicella 2016.1 Start Date: 1 st April 2016 Expiry Date: 31 st March 2019 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS:
More informationPatient Group Direction (PGD) Number (minor amendment June 2014):
Notice to all staff: The Patient Group Directions (PGDs) for the Hertfordshire and South Midlands Area Team may only be used by members of the healthcare professions named on the title page, and only if
More informationClinical Condition Indication:
GG&C PGD ref no: 2016/1366 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Active immunisation against disease
More informationPatient Group Direction No. VI 17. Kathy Wakefield/Lisa Murray. General Practices & TRFT. Relevant Clinical Lead
T i:1 Patient Group Direction (PGD) for The Administration of Meningococcal Group C Conjugate Vaccine (Meningitec /NeisVac-C /Menjugate Kit ) by Registered Nurses employed or commissioned by NHS Rotherham
More informationPatient Group Direction for Rotavirus vaccine Version: ROTAVIRUS (Rotarix ) Start Date: 1 st July 2013 Expiry Date:30 th June 2015
Patient Group Direction for Rotavirus vaccine Version: ROTAVIRUS-2013. 1 (Rotarix ) Start 1 st July 2013 Expiry 30 th June 2015 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS:
More informationConsultation Group: See relevant page in the PGD. Review Date: October 2017
Patient Group Direction For Supply Of Paracetamol Oral Suspension 120mg/5mL For Prevention Of Post Immunisation Fever Following Administration Of Meningococcal Group B Vaccine (Bexsero ) By Community Pharmacists
More informationSouth Staffordshire and Shropshire Healthcare NHS Foundation Trust
South Staffordshire and Shropshire Healthcare NHS Foundation Trust Document Version Control Document Type and Title: Authorised Document Folder: Immunisation Policy YELLOW - Clinical New or Replacing:
More informationCONJUGATE MENINGOCOCCAL (ACWY) VACCINE
Cumbria & Lancashire Vaccine PGD Group ADVISORY INFORMATION FOR USE WITH PATIENT SPECIFIC DIRECTION OR INDIVIDUAL PRESCRIPTION SIGNED BY GP OR NON-MEDICAL PRESCRIBER. CONJUGATE MENINGOCOCCAL (ACWY) VACCINE
More informationNATIONAL PATIENT GROUP DIRECTION FOR SUPPLY OF PARACETAMOL ORAL SUSPENSION
NATIONAL PATIENT GROUP DIRECTION FOR SUPPLY OF PARACETAMOL ORAL SUSPENSION 120 mg/5ml FOR PREVENTION OF POST IMMUNISATION FEVER FOLLOWING ADMINISTRATION OF MENINGOCOCCAL GROUP B VACCINE (BEXSERO ) BY AUTHORISED
More informationPATIENT GROUP DIRECTION (PGD) Supply of potassium iodide 65mg tablets to adults and children exposed to, or at risk of exposure to radioactive iodine
PHE publications gateway number: PATIENT GROUP DIRECTION (PGD) Supply of potassium iodide 65mg tablets to adults and children exposed to, or at risk of exposure to radioactive iodine For the supply of
More informationChange history Version number Change details Date Updated for National ACWY programme to be implemented August June 2015.
Patient Group Direction for Conjugate Meningococcal ACWY vaccine Version: MEN ACWY CONJUGATE 2015.1 Start 1 st August 2015 Expiry 31 st July 2018 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING
More informationPatient Group Directions (PGDs)
Patient Group Directions (PGDs) Document level: Trustwide (TW) Code: MP2 Issue number: 4 Lead executive Authors details Type of document Target audience Document purpose Medical Director Senior Clinical
More informationAdministration of Tuberculin Purified Protein Derivative (PPD) 2TU per 0.1ml to patients attending BCG clinics with identified TB at risk factors.
Administration of Tuberculin Purified Protein Derivative (PPD) 2TU per 0.1ml to patients attending BCG clinics with identified TB at risk factors. Special notes PPD is an unlicensed medicine and therefore
More informationpatient group direction
REVAXIS v01 1/12 REVAXIS (DIPHTHERIA, TETANUS AND POLIOMYELITIS (INACTIVATED) VACCINE (ADSORBED, REDUCED ANTIGEN(S) CONTENT)) PGD Details Version 1.0 Legal category Staff grades Approved by POM Paramedic
More informationPatient Group Direction for HEPATITIS A AND TYPHOID VACCINE. Version No.: 4/2014. Hitesh Patel Pharmaceutical Adviser, NHS Telford & Wrekin CCG
Document Title: Patient Group Direction for HEPATITIS A AND TYPHOID VACCINE PCT Doc Ref.: Local Doc Ref.: PGD Version No.: 4/2014 Author/Owner: File Reference: Document Overseeing Group: Hitesh Patel Pharmaceutical
More informationPATIENT GROUP DIRECTION
Midlands and East (Central Midlands) PATIENT GROUP DIRECTION NHS England Midlands and East (Central Midlands): for use in South Midlands and Hertfordshire Patient Group Direction for the administration
More informationADVANCE PREPARATION OF INSULIN FOR PATIENTS TO ADMINISTER AT HOME
STANDARD OPERATING PROCEDURE ADVANCE PREPARATION OF INSULIN FOR PATIENTS TO ADMINISTER AT HOME First Issued July 08 Issue Version Two Purpose of Issue/Description of Change Planned Review Date To promote
More informationPatient Group Direction (PGD) Number :
Notice to all staff: The Patient Group Directions (PGDs) for the Central Midlands Area may only be used by members of the healthcare professions named on the title page, and only if each professional has
More informationClinician Responsible for Training and Review: Emergency Department Consultant
Patient Group Direction for the supply and/or administration of Paracetamol Oral Suspension 250mg/5ml (Paracetamol paediatric suspension) to children receiving treatment from NHS Borders services. This
More informationPatient Group Direction for Measles, Mumps & Rubella Vaccine. PGD Version No.: 7/2013.
Document Title: Patient Group Direction for Measles, Mumps & Rubella Vaccine Area Team Doc Ref.: PGD Version No.: 7/2013 Doc Ref.: http://www.england.nhs.uk/mids-east/ss-at/immunisations/ Author: Owner:
More informationDeveloped By Name Signature Date
Patient Group Direction 2156 version 2.0 Administration of Ipratropium 250mcg/ml Nebuliser Solution in Acute Asthma by Registered Practitioners employed by Torbay and South Devon NHS Foundation Date of
More informationDirection Number: - NECSAT 2014/017
Patient Group Direction (PGD) for the Administration of HEPATITIS B VACCINE For Infants by Registered Professionals to Individuals Accessing NHS Services in Durham, Darlington, Tees (DDT) and Cumbria,
More informationPATIENT GROUP DIRECTION
Midlands and East (Central Midlands) PATIENT GROUP DIRECTION NHS England Midlands and East (Central Midlands) Patient Group Direction for the administration of Bexsero suspension for injection (Meningococcal
More informationPATIENT GROUP DIRECTION
PATIENT GROUP DIRECTION Supply / Administration of: By: Pharmacists Azithromycin 250mg capsules for Chlamydia In: Community Pharmacy It is the responsibility of the professional working under this PGD
More informationPatient Group Direction For The Pre-Exposure Prophylactic Administration Of Rabies Vaccine By Nurses And Pharmacists Working Within NHS Grampian
NHS Grampian Patient Group Direction For The Pre-Exposure Prophylactic Administration Of Rabies Vaccine By Nurses And Pharmacists Working Within NHS Grampian Lead Author: Consultation Group: Approver:
More informationPATIENT GROUP DIRECTION (PGD)
PHE publications gateway number: 2017015 PATIENT GROUP DIRECTION (PGD) Administration of Hepatitis B recombinant DNA (rdna) vaccine (adsorbed) to individuals who are 15 years of age or over and are on
More informationpatient group direction
ACICLOVIR v01 1/8 ACICLOVIR PGD Details Version 1.0 Legal category Staff grades Approved by POM Paramedic (Non-ECP) Nurse (Non-ECP) Emergency Care Practitioner (Paramedic) Emergency Care Practitioner (Nurse)
More informationPatient Group Direction (PGD) Number :
Notice to all staff: The Patient Group Directions (PGDs) for the Hertfordshire and South Midlands Area Team may only be used by members of the healthcare professions named on the title page, and only if
More informationPatient Group Direction For The Administration Of Rotavirus Vaccine Rotarix By Nurses, Midwives and Health Visitors Working Within.
NHS Grampian Patient Group Direction For The Administration Of Rotavirus Vaccine Rotarix By Nurses, Midwives and Health Visitors Working Within NHS Grampian Lead Author: Consultation Group: Approver: Medicines
More informationCALDERDALE PRIMARY CARE TRUST
CALDERDALE PRIMARY CARE TRUST PATIENT GROUP DIRECTION FOR THE SUPPLY AND ADMINISTRATION OF MEDICINES BY NON- MEDICAL PERSONNEL Progestogen-only emergency contraception for use in Community Pharmacies APPROVED
More informationDirection Number: - NECSAT 2014/014
Patient Group Direction (PGD) for the Administration of COMBINED DIPHTHERIA, TETANUS, ACELLULAR PERTUSSIS AND INACTIVATED POLIOMYELITIS VACCINE (Repevax / Infanrix IPV ) by Registered Professionals to
More informationDirection Number: - NECSAT 2015/001
Patient Group Direction (PGD) for the Administration of HEPATITIS A VACCINES by Registered Professionals to Individuals Accessing NHS Services in Cumbria and North East Sub Region (NHS England North) YOU
More informationVersion Number: 02. Patient Group Direction drawn up by: Jayne Bruce - Deputy Director of Nursing Standards and Safety Sussex
PATIENT GROUP DIRECTION (PGD) FOR THE ADMINISTRATION OF INFLUENZA VACCINE BY REGISTERED NURSES (PEER VACCINATORS) TO STAFF WORKING FOR SUSSEX PARTNERSHIP NHS FOUNDATION TRUST Version Number: 02 Patient
More informationvaccinators and criteria for pharmacist vaccinators
Appendix 4: Authorisation of vaccinators and criteria for pharmacist vaccinators Appendix 4: Authorisation of vaccinators and criteria A4.1 Protocol for authorisation of vaccinators and pharmacist vaccinators
More informationClinician Responsible for Training and Review: Emergency Department Consultant
Patient Group Direction for the Supply of Salbutamol Inhaler to patients receiving treatment from NHS Borders Emergency Department/Out of Hours/Minor Injury Units This document authorises the supply or
More informationPATIENT GROUP DIRECTION (PGD) FOR THE ADMINISTRATION OF COMBINED HEPATITIS A&B VACCINE
PATIENT GROUP DIRECTION (PGD) FOR THE ADMINISTRATION OF COMBINED HEPATITIS A&B VACCINE Valid from: June 2016 Review date: May 2018 Expiry date: June 2018 Developed by Name Job Title Signature Date Senior
More informationAdministration of shingles (herpes zoster) vaccine (live) Zostavax. Version 7.0 updated for programme from September 2017 to August 2018
Patient Group Direction template Administration of shingles (herpes zoster) vaccine (live) Zostavax Version 7.0 updated for programme from September 2017 to August 2018 This specimen Patient Group Direction
More informationPatient Group Direction
Patient Group Direction For the supply and administration of PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT) PNEUMOVAX II Vaccine By Registered Nurse/Midwife/Health Visitor To Adults and children over
More informationPatient Group Direction (PGD) Number :
Notice to all staff: The Patient Group Directions (PGDs) for the Hertfordshire and South Midlands Area Team may only be used by members of the healthcare professions named on the title page, and only if
More informationPatient Group Direction for the Administration of Hepatitis A vaccine
Patient Group Direction for the Administration of Hepatitis A vaccine This PGD must be read in conjunction with the core PGD (Reference: NHSE(LR)/PGD/Core PGD for Immunisations), which details information
More informationDirection Number: - NECSAT 2014/007
Patient Group Direction (PGD) for the Administration of COMBINED LOW DOSE DIPTHERIA, TETANUS AND INACTIVATED POLIO VACCINE (Td/IPV Revaxis ) by Registered Professionals to Individuals Accessing NHS Services
More informationPatient Group Direction For the supply and administration of
Patient Group Direction For the supply and administration of Vi Capsular Polysaccharide Typhoid Vaccine(Ty2) Brands TYPHERIX Vaccine TYPHIM Vi Vaccine To adults and/or children over 2 years of age Or Oral
More informationfor adults engaged with the Family Wellbeing Service Isle of Wight In Community Pharmacy for Isle of Wight Public Health Commissioned Services
The supply of Champix (Varenicline) Tablets 500mcg and 1mg by registered community pharmacists for smoking cessation / management of nicotine withdrawal for adults engaged with the Family Wellbeing Service
More informationJob Title Name Signature Date. Director of Nursing Angela Wallace Signed Angela Wallace 30/6/2014
PATIENT GROUP DIRECTIONS FOR SUPPLY OF VARENICLINE (CHAMPIX ) BY AUTHORISED COMMUNITY PHARMACISTS WORKING IN FORTH VALLEY Protocol Number 445 Version 1 Date protocol prepared: June 2014 Date protocol due
More informationPATIENT GROUP DIRECTION
Midlands and East (Central Midlands) PATIENT GROUP DIRECTION NHS England Midlands and East (Central Midlands): for use in South Midlands and Hertfordshire Patient Group Direction for the administration
More informationPatient Group Direction For the supply and administration of
Patient Group Direction For the supply and administration of Adsorbed low dose DIPHTHERIA/TETANUS/acellular PERTUSSIS/ inactivated POLIO REPEVAX Vaccine (dtap/ipv) By Registered Nurse/Midwife/Health Visitor
More informationPatient Group Direction for the Administration of Human Papilloma Virus (HPV) Vaccine (Gardasil and Cervarix )
Patient Group Direction for the Administration of Human Papilloma Virus (HPV) Vaccine (Gardasil and Cervarix ) This PGD must be read in conjunction with the core PGD (Reference: NHSE(LR)/PGD/Core PGD for
More informationPatient Group Direction For The Administration Of Hepatitis B Vaccine By Registered Nurses And Pharmacists Working Within NHS Grampian
Patient Group Direction For The Administration Of Hepatitis B Vaccine By Registered Nurses And Pharmacists Working Within NHS Grampian Lead Author: Medicines Management Specialist Nurse Consultation Group:
More informationPATIENT GROUP DIRECTION (PGD) FOR THE SUPPLY OR ADMINISTRATION OF LEVONORGESTREL 1500 MICROGRAM TABLET (e.g LEVONELLE 1500 ) PGD
This Patient Group Direction () must only be used by registered pharmacists who have been named and authorized by their organization to practice under it. The most recent and in date final signed version
More informationExpiry Date: July 2009 Template Version: Page 1 of 7
Salbutamol nebules YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT NPGD2007/355 (supersedes 2004/177) Clinical Condition Indication: Inclusion
More informationPatient Group Direction for GLUCAGON (Version 02) Valid From 1 October September 2019
Version Control This PGD has been agreed by the following organisations FCMS Doncaster CCG Lancashire CCGs including East Lancashire, Fylde and Wyre and North Lancashire CCGs Change history 31/07/17 V02
More informationPATIENT GROUP DIRECTIONS POLICY
PATIENT GROUP DIRECTIONS POLICY To be read in conjunction with the Medicines Policy and the Controlled Drugs Policy Version: 5 Ratified by: Senior Managers Operations Group Date ratified: August 2015 October
More informationHepatitis B in Travellers
Hepatitis B in Travellers Please find product Prescribing Information at the end of this presentation Hepatitis B A serious blood-borne liver infection, which can cause both acute and chronic disease 1,2
More informationpatient group direction
SALBUTAMOL v01 1/12 SALBUTAMOL PGD Details Version 1.0 Legal category Staff grades Approved by POM Paramedic (Non-ECP) Nurse (Non-ECP) Emergency Care Practitioner (Paramedic) Emergency Care Practitioner
More informationDirection Number: - NECSAT 2014/003
Patient Group Direction (PGD) for the Administration of MEASLES, MUMPS AND RUBELLA VACCINE (MMR) by Registered Professionals to Individuals Accessing NHS Services in Durham, Darlington, Tees (DDT) and
More informationPatient Group Direction for LIDOCAINE INJECTION (Version 02) Valid From 1 October September 2019
Version Control This PGD has been agreed by the following organisations FCMS PDS Medical Doncaster CCG Lancashire CCGs including East Lancashire, Fylde and Wyre and North Lancashire CCGs Change history
More informationConsultation Group: Dr Amalia Mayo, Paediatric Consultant. Review Date: March Uncontrolled when printed. Version 2. Executive Sign-Off
Policy For The Adjustment Of Insulin Injections By Paediatric Diabetes Specialist Nurses/Community Paediatric Nurses Diabetes Working With Children Within NHS Grampian Co-ordinators: Lead Paediatric Diabetes
More information